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Abstract 
Breast cancer is the most common cancer in women and the second leading cause of female 
cancer-related deaths. Low oxygen tension (hypoxia) arises in most solid tumors due to the 
imbalance of oxygen supply and consumption. Hypoxia is an adverse prognostic marker in 
various cancer types. Recently, the Gilkes lab developed a hypoxia fate-mapping system, which 
permanently marks hypoxic cells to enable the mapping of their fate during tumorigenesis. This 
dual lentiviral vector system was transduced into MDA-MB-231 cells, which permanently switch 
from DsRed to GFP when exposed to hypoxia. In a parallel study, a hypoxia fate-mapping 
transgenic mouse model forms spontaneous breast tumors, whose cells permanently switch from 
TdTomato to GFP expression under hypoxia. We utilized this model to produce a three-
dimensional cell culture that allows for better recapitulation of the tumor microenvironment, but 
the extent of oxygen diffusion through the 3D matrices is poorly understood. 
 We investigated the O2 content in 3D matrices using organoids generated from the breast 
tumors of the triple transgenic mouse model. First, these organoids were exposed to normoxia 
and hypoxia to determine the most sensitive mouse model: EF1-CREODD(+/-)TdTm(+/+). Next, 
to characterize our model, organoids, embedded in Matrigel, demonstrated an inverse correlation 
between exposed O2 conditions and GFP expression. At 20% O2, organoids embedded in 
Matrigel formed GFP+ hypoxic cores; however, organoids cultured in collagen presented a more 
invasive phenotype where hypoxic cores did not develop. Then, the O2 depletion of organoids 
with varied cell density, scaffold material, and cell activity was measured using OXNANO 
nanoprobes. For organoids cultured in Matrigel, the O2 levels decreased with increasing seeding 
density, while the collagen embedded organoids remained constant over the 10-day time-course. 
iii 
Finally, O2 depletion was measured in hypoxia fate-mapping MDA-MB-231 derived spheroids 
embedded in Matrigel, where the O2 level decreased with increasing initial cell density. Our 
work suggests that Matrigel is a better platform to study growth and spontaneous hypoxia, 
whereas collagen is better for invasion studies. Nevertheless, more work is warranted into the 
hypoxic core formation to develop a reproducible 3D tumor model that recapitulates the tumor 
microenvironment to better understand hypoxia in cancer. 
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1.1 Breast Cancer 
Breast cancer is the most prevalent cancer in women. The American Cancer Society estimates 
there will be 276,000 new cases of breast cancer for females in the United States in 2020, 
equating to approximately 30% of all cancer incidences1. Likewise, 12.8% or 1 in 8 women will 
develop breast cancer in her lifetime1. Furthermore, breast cancer is the second leading cause of 
cancer-related deaths with more than 42,000 deaths estimated for 2020, representing 15% of 
cancer deaths in women1. Although the number of breast cancer deaths declined by 40% from 
1989 to 2017, the death rate stabilized in recent years after more than two decades of decline2. 
Breast cancer mortality is mostly caused by metastasis, equating to 90% of all cancer attributed 
deaths2.  Consequently, the five-year survival rate is 90% for all breast cancer, but drops to 27% 
for metastatic breast cancer1. Primary tumors can be successfully removed via surgery or treated 
with radiation, but after the cells disseminate to distant organs in the body, these metastases are 
very difficult to treat. Despite the advancements in cancer diagnosis and treatment, there is still 
no techniques for definitively identifying patients who will metastasize or relapse2.  
Metastasis is the least understood process of tumorigenesis. Tumor cells must acquire a 
motile phenotype for the initiation process to begin, which is mediated by a process called the 
epithelial mesenchymal transition (EMT). Formation of new blood vessels is essential for further 
growth and allows tumor cell dissemination at distance sites3. Then, the cell can detach from the 
primary vascularized tumor, invade the surrounding tissue, intravasate into nearby blood vessels, 
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and circulate in the vascular system4. Some of the circulating tumor cells (CTCs) in the vascular 
system adhere to blood vessel walls. These cells are able to extravasate and migrate into the local 
tissue, where they can colonize in sites such as the brain, bone, lung, and liver in the case of 
breast cancer. There has been an increasing amount of evidence revealing oxygen (O2) content of 
tumor tissue as an important determinant of metastasis. 
 
1.2 Hypoxia 
Most solid tumors, larger than 1 mm3, contain hypoxic regions because of the inability to provide 
the growing tumor mass with adequate amounts of O2
3. These regions develop in 90% of solid 
cancers5. Hypoxia (low oxygen tension) and anoxia (no measurable oxygen) arise due to an 
imbalance between oxygen supply and consumption6. In normal tissues, the O2 supply matches 
the metabolic requirements; however, in solid tumors, the elevated proliferation causes an 
increased consumption rate that may outweigh the insufficient oxygen supply, resulting in 
regions of hypoxia7. There are two types of hypoxia: acute and chronic8. Acute, or ischemic 
hypoxia, is perfusion-limited oxygen delivery due to abnormal vasculature network and high 
interstitial pressure, resulting in abnormal blood flow, which is often transient9. Chronic hypoxia 
is diffusion-limited hypoxia, which is caused by large diffusion gradients created by the high 
proliferation rate of cancer cells, inadequate blood vessel formation, and adverse diffusion 
geometry5,7. Solid tumors arise without existing vasculature and the new inadequate blood 
vessels that form are leaky and have chaotic architecture and non-laminar blood flow10. The 
oxygen diffuses 100-200 µm away from the nutritive blood vessels, depending on the local 
oxygen concentration in the blood and the rates of oxygen consumption of the surrounding 
cells1,6. Hypoxic regions occur approximately 200 µm away from blood vessels10. The degree of 
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hypoxia experienced by a cell is determined by its proximity to the arterial blood supply and 
rates of O2 consumption by the neighboring cells
11. Farther from the blood vessels, necrosis 
develops as a direct result of limited oxygen and nutrients, suggesting that given sufficient time 
hypoxic cells will become necrotic12.  
The hypoxic environment in tumors selects for cells that  respond and adapt to oxygen 
deficiency10. Cells require an adequate and continuous supply of oxygen to use as the terminal 
electron acceptor for the process of mitochondrial respiration, which generates ATP13. Hypoxia 
leads to insufficient oxygen for efficient ATP production so the hypoxic tumor cells turn to 
anaerobic glycolysis to meet their energetic demand9,10,14. Similarly, tumor cells respond to low 
levels of oxygen with distinct changes in gene expression that promote cell survival and tumor 
progression. These pathways are involved in cell proliferation, angiogenesis, apoptosis, 
metabolism, and inflammation9,15.  
 
1.2.1 Hypoxia and Breast Cancer 
Several studies indicate low oxygen tension in tumors is an adverse prognostic marker in 
various cancer types3,9,16. Notably, 25-40% of invasive breast cancer exhibits hypoxic regions17. 
On average, the partial pressure of oxygen (pO2) in normal human breast tissue is 65 mmHg 
(~8.5% O2), while breast tumors have a range of 2.5 to 28 mmHg (0.3-3.6% O2)
18. Patients with 
a pO2 of less than 10 mmHg are at an increased risk of metastasis and mortality
19. Hypoxic 
tumors are found to correlate with metastatic occurrences and a number of studies demonstrate 
an inverse correlation between tumor oxygenation and clinical outcome8–10,16. Hypoxic cells have 
reduced drug delivery for chemotherapy, intrinsic radioresistance, apoptosis resistance, a pro-
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The most well-characterized hypoxia response pathway is mediated by the hypoxia-inducible 
factors (HIFs). HIFs (HIF-1 and HIF-2) permit tumor cells to adapt by facilitating oxygen 
delivery and adaptation to oxygen deprivation by inducing hypoxia responsive genes20,21. HIF-1 
is a heterodimeric transcription factor consisting of an oxygen regulated, HIF-1α, and, a 
constitutively expressed, HIF-1β/ARNT (aryl hydrocarbon receptor nuclear translocator)18,22. 
HIF-1α expression is precisely regulated by cellular O2 concentration. In normoxia, HIF-1α is 
polyubiquitinylated and targeted for proteasomal degradation22. HIF-1α contains an oxygen-
dependent degradation domain within which there is a binding domain for the tumor suppressor 
von Hippel-Lindau protein (pVHL)3. Under normal oxygen conditions, prolyl hydroxylase 
domain (PHD) proteins hydroxylate HIF-1α23. After hydroxylation, pVHL organizes the 
assembly of a complex that activates the E3 ubiquitin ligase which then ubiquitinylates HIF-1α, 
targeting for proteasomal destruction3. Conversely, during hypoxia, the unmodified HIF-1α no 
longer interacts with pVHL, PHD enzymes lose their activity, and the active form of HIF-1 
accumulates15. 
Hypoxia results in the rapid accumulation of HIF-1α to the nucleus where it dimerizes 
with HIF-1β and leads to the transcriptional activation of hundreds of target genes by binding to 
a DNA sequence termed the hypoxia -responsive element (HRE)22,23. Three hours of hypoxia in 
vitro is sufficient time to observe HIF-1α stabilization in cancer cells23. However, after a few 
days, there is a decrease in HIF-1α to lower expression levels. Similar to HIF-1α, HIF-2α is also 
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regulated by oxygen-dependent hydroxylation. HIF-1α and HIF-2α are structurally similar in 
DNA binding and dimerization domains, but differ in their transactivation domains24. Under 
hypoxia, HIF-2α also dimerizes with HIF-1β and in general, regulates similar genes to HIF-1α20. 
 Stabilization of HIFs are correlated with poor clinical outcomes, high mortality rates, 
chemoresistance, and metastasis in several types of cancer10,23. These transcription factors induce 
the expression of genes that contribute to metabolic reprogramming, angiogenesis, and changes 
in apoptosis5,25. HIFs also contribute to metastasis through the downregulation of adhesion 
molecules and the increase in motility by regulating EMT as well as inducing cell migration and 
invasion through matrix degrading enzymes15. HIF-1α over expression in tumor biopsies is 
correlated with increased patient mortality in breast cancer23. Similarly, HIF-2α is associated 
with distant recurrence and poor outcome6. Although studies indicate that intratumoral hypoxia 
and increased HIF-1α expression are associated with aggressive cancers, the ability to identify 
patients at risk is still limited21. 
 
1.3 Oxygen Characterization 
The detection of the extent of tumor hypoxia could potentially enable appropriate patient 
classification and allow clinicians to make informed decisions regarding the therapy 
management for the patient26. Current methods for gauging tumor hypoxia are to directly 
measure O2, assess physiologic processes involving oxygen molecules, and evaluate the 
expression of endogenous markers26. The direct measurement of O2 in human tumor tissue has 
been performed using polarographic needle electrodes or fiber-optic probes, but with these 
methods, the individual cells cannot be visualized or separated9,27. Indirect O2 measurements 
have been performed using immune labeling of endogenous markers, such as transcriptional 
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targets of HIFs, and by using chemical hypoxia probes such as pimonidazole9,27. Furthermore, 
clinical methods include magnetic resonance spectroscopy, X-ray imaging, optical imaging, and 
positron emission tomography9,27,28. 
 
Figure 1: Hypoxia fate-mapping MDA-MB-231 cell line a. The Gilkes lab developed two lentiviral vectors that 
were used to generate a hypoxia fate-mapping MDA-MB-231 cell line. Under normoxic conditions, DsRed is 
constitutively expressed. b. Under hypoxic conditions, the expression of the Cre enzyme results in the cleavage of 
DsRed from vector 2 causing the expression of GFP. c. Fluorescent images of MDA-MB-231 hypoxia fate-mapping 
cells after exposure to 20% and 0.5% O2 conditions for 11 days. 
 
1.4 Hypoxia Fate-Mapping System 
Recently, the Gilkes lab developed a hypoxia fate-mapping system, which permanently marks 
hypoxic cells and enables the mapping of their fate during tumorigenesis29. This dual-vector 
system can be used to track hypoxic cells that undergo reoxygenation during metastasis. The first 
vector contains 4 HIF-DNA binding sequences (HRE), which transcriptionally controls a Cre 
gene modified with an oxygen-dependent degradation domain (ODD) (Fig. 1). The second vector 
has a constitutively active promoter (CMV) followed by a red fluorescent reporter protein 
(DsRed) with a stop codon flanked by tandem loxP sites followed by eGFP, a green fluorescent 
protein (Fig. 1). Under normal oxygen conditions, the cells express DsRed (Fig. 1a). However, 
under hypoxia, HIF stabilization causes binding to the repetitive HRE sequences, which ensure 
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an irreversible DsRed to GFP reporter switch, and the transcription of CRE-ODD, leading to the 
cleavage of DsRed and permanent GFP expression (Fig. 1b). Our system is tightly controlled to 
low O2 levels (<0.5%) and does not change under physiological conditions that mimic normal 
breast tissue (8% O2) (Fig. 1c).  
 
1.5 Two- versus Three-dimensional Cell Culture 
Cell culture is essential for modern biomedical research to improve our understanding of tissue 
morphology, cell biology, and mechanisms of disease29–31. In cancer research, cell culture and 
mouse models are the primary tools used to understand tumor biology and optimize treatments. 
Two-dimensional (2D) cell cultures are the most utilized and consist of primary cell cultures and 
established cell lines deposited in cell banks. Primary cell cultures have difficulties with isolation 
and short life span, while established cell lines do not capture the true variety between cancer 
types30. The advantages of working with cell lines is that they are homogenous, simple to grow 
and propagate, and allow for high-throughput screenings32. The major challenges with 2D 
cultures are potential changes of cell morphology, method of division, and a loss of 
phenotype30,33. Cell cultures in 2D grow on a monolayer attached to glass or plastic dishes, 
where they are exposed to an unlimited and uniform source of oxygen and nutrients30. 
Additionally, 2D cell cultures lack variability of nutrients, genetic heterogeneity, and the 
interaction with matrix protein and other cell types34. Conversely, mouse models capture 
heterogeneity, but do not allow for high throughput screening.  
 Three-dimensional models could be the intermediate between 2D and animal studies. 
Using 3D cultures may allow for better recapitulation of tumor environments, leading to a better 
understanding of cancer biology and treatment options. Cells can be cultured in 3D by 
8 
suspension in concentrated medium or gel-like substances, or on a scaffold30. Moreover, studies 
have shown that there are great similarities between the morphology and behavior of cells in a 
tumor mass and those in 3D culture conditions30. Markedly, cells cultured on ECM restore some 
mammary specific gene expression35. The main challenges with 3D cultures are that they are less 
efficient, have a shorter life-span, and have more difficult repeatability when compared to 2D 
cultures36. Additionally, 3D cultures increase complexity for imaging, analysis, and 
quantification37. These models are generated using cellular spheroids, organoids, multilayered 
cultures of cancer cells, or tumor slices embedded in various matrices33. 
 
1.5.1 Matrices used in 3D Culture 
Natural materials, such as collagen, hyaluronic acid, and chitosan, and synthetic materials, such 
as, polyethylene glycol, poly(lactic‐co‐glycolic) acid, and polycaprolactone have been used in 
3D cell cultures. Natural materials are more variable and expensive to manufacture than 
engineered synthetic materials. These materials are used to construct scaffolds to physically 
support cell adhesion and growth as well as promote self-assembly of cells into 3D clusters33. 
For instance, two major matrices used in 3D cultures are collagen type I and Matrigel. Fibrillar 
collagen I, a main structural protein in mammary glands, plays an important role in the 
development of breast cancer38and is commonly used to study 3D migration of many cell types38.  
  Matrigel is a basement-membrane-like matrix, which is a complex mixture of over 1000 
proteins, rich in collagen type IV, laminin, and nidogen33,35. The advantages of Matrigel are its 
ease of handling, fast gelling kinetics, and readily available production with high quality 
control33. However, Matrigel has some limitations, such as lack of control of formulation and 
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gelation kinetics33. Additionally, Matrigel could have issues with reproducibility due to 
inconsistent composition and batch-to-batch variability. 
 
1.5.2 Spheroid Model 
Spheroids are the simplest in vitro model of solid tumors and are generated using cancer cell 
lines. Epithelial cancer cells form intercellular adhesions and self-assemble into compact clusters 
on nonadherent surfaces or within a 3D matrix. The 3D morphology of spheroids establishes 
close cell-cell and cell-matrix adhesions33. Moreover, the spheroids experience nonuniform 
concentrations of oxygen and nutrients, which can lead to oxygen gradients, causing hypoxic 
cores in the center of the spheroid31,33. Spheroids can be cultured in suspension or in collagen, 
Matrigel, and synthetic scaffolds, which allow the study of migration and invasion. Spheroids 
have the advantages of well-defined geometry, cell-cell and cell-ECM interactions, and 
reproducibility37. The simplicity and increased tumor mimicry of spheroids promotes the ability 
to conduct high throughput drug screening, basic tumor growth studies, and analysis of cellular 
responses to chemical compounds33. However, spheroids are formed from established cancer cell 
lines, which neglect to capture the complexity and heterogeneity of tumors. To overcome this 
limitation, organoid models may provide more heterogeneity and better recreation of the tumor 
microenvironment.  
 
1.5.3 Organoid Model 
Organoids, created from both normal and tumor tissue, can recapitulate the epithelial architecture 
and physiology of tissues36. When formed from the tumor mass, organoids closely model the in 
vivo tumor characteristics and genetic heterogeneity, which are preserved in culture over 
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time34,39. Organoid cultures provide an attractive platform to test new drug treatments. 
Additionally, multiple organoids can be generated from a single biopsy, facilitating high-
throughput tests of multiple and a combination of drugs using a small amount of tissue40. 
However, organoid models do not entirely recreate a tumor in a 3D environment because they 
still lack stroma, blood vessels, and immune cells34. Unlike spheroid cultures, organoids are 
mainly encapsulated in natural biomaterials, such as Matrigel and collagen. Matrigel embedment 
is the most commonly used structure for organoid cultures33. Breast cancer organoids in Matrigel 
form important features of epithelial development of the ductal microenvironment38. 
Consequently, cancer organoids could fill the gap between cancer cell lines and mouse models 
because of their physiological relevance and ability for creating high-throughput screens32.  
 
1.5.4 Oxygen and 3D Cultures 
The conditions in which cells are cultured can greatly affect the observed biology and 
reproducibility. Oxygen, which is often ignored, could develop gradients, especially in 3D 
cultures. Oxygen diffusion through 3D cultures is limited because it must diffuse from the gas 
and liquid phases through the solid phase of cell clusters, extracellular matrix, and hydrogels41.  
Due to convenience, tumors cells are typically cultured at hyperoxic conditions well above the 
pO2 of human tissues. The air in a cell culture incubator contains 140 mmHg O2 (18.5%)
31. In 
particular, 3D cell cultures experience concentration gradients as a result of the competition 
between diffusion and consumption35. Notably, considering its relatively low solubility in culture 






Hypoxia has been shown to be a negative prognostic factor for solid tumors. Chemoresistance is 
a major factor in the poor clinical outcome of hypoxic tumors. Notably, up to 95% of potential 
drug candidates that are efficacious in preclinical tests are unsuccessful in clinical trials33. Better 
understanding of the organoid model and its recapitulation of the tumor microenvironment could 
provide valuable insight for potential drug screenings. Furthermore, current techniques for 
studying hypoxia result in exposing cells to normoxic and hypoxic conditions, which does not 
fully capture the oxygen gradient within the tumor. Therefore, there is a need for an experimental 
organoid model that can recapitulate tumor hypoxia to examine drug resistance and to study the 
effect of hypoxia on tumor progression and metastasis. 
Although some studies have shown that there exists an oxygen gradient, not much is 
known about how oxygen diffuses through the 3D matrices37,42. Hypoxic cores have been studied 
in some spheroid models, but the extent of this core formation in cultures grown in normoxic 
conditions with the organoid model is poorly understood. The seeding density, time in culture, 
and scaffold material could influence the oxygen level within the overall gel as well as each 
organoid. It is important to consider how oxygen consumption could change over the course of 
an experiment and influence cell culture findings. 
In our lab, we developed organoids from a triple transgenic hypoxia fate-mapping mouse 
model, which causes the permanent switch from TdTomato, a red fluorescent protein, to GFP, a 
green fluorescent protein. We investigated the hypoxic response of the organoids to determine 
the most sensitive mouse model and investigate the differences between organoids embedded in 
Matrigel and collagen. We also characterized the O2 content of organoids in Matrigel and 
collagen and compare it to our hypoxia fate-mapping MDA-MB-231 spheroid model.  
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Chapter 2 
Materials and Methods 
2.1 Cell Culture 
Human breast carcinoma cells, MDA-MB-231 (ATCC) were maintained in Dulbecco’s modified 
Eagle’s medium (DMEM) (Sigma-Aldrich) supplemented with 10% Fetal Bovine Serum (FBS, 
Corning) and 1% penicillin/streptomycin (Invitrogen). Cells were cultured in a humidified 
atmosphere at 37°C with 5% CO2. Hypoxic cells were maintained inside a customized sealed 
chamber (McCoy) with a humidified atmosphere maintained at 37°C with 0.5% O2, 5% CO2, and 
94.5% N2.  
 
2.2 Hypoxia Fate-mapping Cell Line 
MDA-MB-231 breast cancer cells were transduced with two independent lentiviral vectors to 
generate a hypoxia fate-mapping cell line. The first lentiviral vector encodes CMV-loxp-DsRed-
loxp-eGFP (Fig. 1). This vector contains a DsRed gene followed by a stop codon, which is 
flanked by two loxp sites, and in front of an eGFP gene (Fig. 1a). Under normal oxygen 
conditions, the cells express DsRed, a red fluorescent protein. The second lentiviral vector 
encodes 4xHRE-minTK-CRE-ODD that drive Cre production. Therefore, under hypoxia, the 
deletion of the DsRed gene occurs and eGFP, a green fluorescent protein, is permanently 





Figure 2: Hypoxia fate-mapping transgenic mouse model a. (1) The Gilkes lab generated a transgenic mouse that 
produces Cre recombinase in cells exposed to hypoxia. The hypoxia-inducible Cre mouse was crossed with a (2) 
mT/mG reporter mouse (B6.129(Cg)-Gt(ROSA)26Sor, Jackson Labs; 007676) to generate a double-transgenic (2T) 
mouse. The 2T mouse was bred with (3) a mouse that develops spontaneous breast tumors due to the expression of 
the PyMT oncogene that is driven by the mammary specific MMTV promoter. b. Transgene design of (1) the EF1-
CRE-ODD gene integrated into the oxygen responsive mouse, (2) mT/mG reporter mouse, and (3) MMTV-PyMT 
expressing mouse. c. Transgenic genes are located on either one or both of the chromosomes. d. Schematic of the 
PCR assay used to identify mice that are positive for transgene integration. (1) Ear clippings of the 3T mice were (2) 
lysed to generate genomic DNA. (3) DNA was PCR amplified using the primers each transgene shown in b. The 
PCR product was separated using (4) gel electrophoresis. (5) The gel was imaged and (6) the mice with the genes of 
interest were maintained for further experimentation. 
 
2.3 Hypoxia Fate-mapping Transgenic Mouse Model 
The EF1-CRE-ODD sequence was inserted via pronuclear injection into mouse embryos. This 
oxygen responsive mouse was bred with tdTomato-floxed GFP (mT/mG) reporter mouse 
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(B6.129(Cg)-Gt(ROSA)26Sor, Jackson Labs, 007676) as shown in Figure 2. A female double 
transgenic hypoxia fate-mapping mouse was crossed with a male mouse that generates 
spontaneous breast tumors using the MMTV promoter driven PyMT oncogene (FVB/N-
Tg(MMTV-PyMT), Jackson Labs, 002374). Female triple-transgenic mice are genotyped and 
kept for future experiments. 
Upon sacrificing, the mammary fat pads (MFP) located on the right side of the mouse 
were removed, fixed with 4% PFA, and incubated at 4°C for 4 hours. Then, the tumors were 
placed in 30% sucrose (Sigma-Aldrich) and left at 4°C overnight. Next, the tumor tissue was 
embedded in OCT media (Fisher Scientific) and flash frozen using liquid nitrogen. The cryotome 
CM1100 (Leica) was used to generate tissue sections that were mounted onto Superfrost Plus 
Microscope Slides (Fisher Scientific). The tissue was stained with DAPI (1:1000) for 15 min at 
room temperature. Then, the slides were imaged using the RFP, GFP, and DAPI channels to 
evaluate the GFP and TdTom expression in the tissue. The samples were imaged using a 
Cytation 5 with an Olympus (LUCPLFLN 40XPh) phase objective (BioTek Instruments). 
 
2.4 Genotyping 
A PCR assay was used for the detection of transgenes as shown in Figure 2d. A clipping of the 
mouse’s ear was lysed using lysis buffer (1M Tris pH 8.0, 5M NaCl, 0.5M EDTA, 10% 
Tween20, 10% NP-40 and ~40 μg of proteinase K). After being incubated overnight at 37°C with 
5-minute interval shaking (1450 rpm), proteinase K was deactivated at 95°C for 2 minutes. Then, 
the genomic DNA was PCR amplified using primers for the 3 transgenes of interest (Table 1) and 
DreamTaq Green (Thermo Scientific) as follows: 95°C for 3 minutes, 40x (95°C for 30 seconds, 
57°C for 35 seconds, 72°C for 35 seconds) and 72°C for 5 minutes. Next, gel electrophoresis was 
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performed using a 2% agarose gel. Images of the gel were captured using Azure eSeries Capture 





MMTV-PYMT GGAAGCAAGTACTTCACAAGGG GGAAAGTCACTAGGAGCAGGG 
HRE CTGCTAACCATGTTCATGCCTTC GACGATGAAGCATGTTTAGCTGGC 
TdTm – Mutant CTT TAAGCCTGCCCAGAAGA TAGAGCTTGCGGAACCCTTC  
TdTm – WT CTTTAAGCCTGCCCAGAAGA AGGGAGCTGCAGTGGAGTAG 
Table 1: Primer Sequences used for Genotyping 
 
2.5 Organoid Culture 
2.5.1 Organoid Processing 
Mammary organoids were derived from transgenic mouse tumors following previously published 
protocols with minor modifications38. Tumors from the mammary fat pad of transgenic mice 
were mechanically disrupted using a blade. Then, the minced tumors were enzymatically 
digested in 2mg/mL of collagenase in Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient 
Mixture F12 (DMEM/F12, Thermo Fisher) and incubated at 37°C for one hour on an orbital 
shaker at 180 rpm (Sigma-Aldrich). This suspension was centrifuged at 1500 x g for 10 minutes. 
The supernatant was discarded and the organoids were resuspended in fresh DMEM/F12 media. 
The suspension was centrifuged again at 1500 x g for 10 minutes and the supernatant was 
discarded. Organoids were digested with DNAse in a final concentration 0.1 mg/mL (Sigma-
Aldrich) for 5 minutes at room temperature. This suspension was spun down for 10 minutes at 
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1500 x g. After resuspension in fresh media, the suspension was differentially centrifuged (4x) 
by pulsing to 1500 x g for 2 seconds. The isolated organoids were frozen for future experiments 
using 10% DMSO in Dulbecco’s Modified Eagle’s Medium/Ham’s Nutrient Mixture F12 
(DMEM/F12) supplemented with 1% Insulin-Transferrin-Selenium (ITS), 1% 
penicillin/streptomycin, and FGF (40 ng/mL) (Sigma-Aldrich). 
 
2.5.2 Organoid Culture 
Organoids were thawed, resuspended in fresh media, and centrifuged at 1500 x g for 10 minutes. 
The supernatant was discarded and the organoids were resuspended thoroughly in fresh media. 
Then, the total number of organoids were calculated by transferring 50 μL of the suspension to a 
petri dish and counting the number in a sample volume under a microscope. The desired number 
of organoids were embedded either in Matrigel (Corning) or soluble rat tail type I collagen 
(Corning) and 100 μL of gel were plated in the center of each well in a 24-well plate. For 
collagen embedment, the 24-well plate was heated on a heating block to 37°C for 20 minutes. 
Collagen was mixed with a 1:1 solution of DMEM/F12 cell medium and reconstitution buffer 
[0.2 HEPES (Sigma-Aldrich) and 0.26 M NaHCO3 (Sigma-Aldrich) in water] to make a final 
concentration of 2mg/mL. NaOH (1 M) was added to neutralize the pH. After plating the 
organoids, the plates were incubated for 30 minutes at 5% CO2 and 37°C. Next, 1 mL of warmed 
DMEM/F12 media supplemented with 1% ITS, 1% penicillin/streptomycin, and FGF (40 
ng/mL) (Sigma-Aldrich) was added to each well. The media was refreshed in each well every 3-
4 days. 
Organoids are incubated under normal conditions overnight before being exposed to 
different oxygen levels. Different oxygen levels were achieved as follows: the InvivO2 
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workstation (Baker) with an ICONIC (Baker) electronically controlled gas-mixing system 
maintained at 37°C and equilibrated at 1% O2, 5% CO2, and 94% N2, customized sealed chamber 
(McCoy) with a humidified atmosphere maintained at 37°C with 0.5% O2, 5% CO2, and 94.5% 
N2 or 10% O2, 5% CO2, and 85% N2, or in a modular chamber (Billups-Rothenberg) flushed 
with a gas mixture containing 5% O2, 5% CO2, and 90% N2 maintained inside an incubator at 
37°C. 
 
2.5.3 Image Processing and Analysis 
Organoids were imaged over time (day 1, 5, 10, and 20) by a Cytation 5 with an Olympus 
(PLAPON 1.25XPh) phase objective (BioTek Instruments) using the RFP and GFP channels. 
During imaging, the stage was incubated at 37°C. The entire well of the 24-well plate was 
captured using an X:Y montage and the image tiles were stitched using the Gen5 Software 
(Biotek). Cellular analysis was performed using the Gen5 software to segment objects and 
identify the size, circularity, mean RFP intensity, and mean GFP intensity of each organoid. 
 
2.5.4 Flow Cytometry Analysis 
Warm trypsin was added to each well and the gels were mechanically disrupted. The plate was 
incubated with trypsin for 10 minutes at 37°C. After being resuspended, they were centrifuged at 
1500 x g for 5 minutes and washed twice with PBS. Then, the organoids were resuspended and 
collected in FACs buffer (PBS, 1% BSA, 0.5 mM EDTA, and 25 μg/ml DNAse). GFP was 
detected in the FITC channel and TdTom was detected in the PE channel using an SH800S Cell 
Sorter (Sony). Organoids created from a mouse with mT/mG and MMTV-PyMT (2T) transgenes 
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were used as a TdTom+/GFP- control. Then, flow cytometry analysis was performed FlowJo 
V10 software (Tree Star, Inc.). 
 
2.6 Confocal Microscopy 
Confocal microscopy was performed on the organoid cultures to visualize individual organoids. 
Wells of a 24-well glass bottom microplate were coated with soluble rat tail type I collagen 
(Corning) in acetic acid (final concentration 50 mg/mL). The plate was incubated at room 
temperature for 1 hour and, then, washed 3X with PBS. Organoids were plated as previously 
described. Confocal microscopy was performed to obtain z projections of organoids using a 
20X/0.80 PlanApo (dry, no DIC) objective and 40×/1.30 PlanNeofluar oil objective in a Zeiss 
LSM780-FCS microscope. The z-stacks were processed via ZEN imaging software (Zeiss).  
 
2.7 Oxygen Monitoring Experiments 
To correlate organoid number with oxygen concentration, different numbers of organoids were 
seeded into 24-well plates. Oxygen measurements were conducted using a REDFLASH system 
(FireStingO2, Pyroscience). OXNANO oxygen nanoprobes were dispersed in Matrigel and 
collagen gels during cell plating. Oxygen levels were measured through the bottom of the well 
once daily using the REDFLASH oxygen meter. The sensor was calibrated daily using 
nanoprobes suspended in water. 
 
2.8 Spheroid Culture 
Hypoxia fate-mapping MDA-MB-231 cells were counted and dispersed in Matrigel and 100 µL 
were placed in the center of the well of a 24-well plate. Then, the spheroids were incubated at 
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37°C for 30 minutes. Next, warmed DMEM media supplemented with 10% FBS and 1% 
penicillin/streptomycin was added to each well. The spheroids were maintained in a humidified 
environment at 37°C and 5% CO2. Then, the plate was imaged in a Cytation 5 using an Olympus 
(PLAPON 1.25XPh) phase objective (BioTek Instruments). 
 
2.9 Statistical Analysis 
The mean values ± standard error of mean (SEM) were calculated and plotted using Graphpad 
Prism 6 software (GraphPad Software, Inc.). One-way and two-way ANOVA and t-tests were 
used to determine significance, indicated in graphs using ****P < 0.0001, ***P < 0.001, **P < 0.01, 




Results and Discussion 
3.1 Establishing a Hypoxia Fate-mapping Organoid Model 
A hypoxia fate-mapping triple transgenic mouse system was recently developed in the Gilkes 
laboratory29 . A mouse engineered to express Cre enzyme in cells at low levels of O2 was 
designed by introducing the EF1-CREODD transgene via pronuclear injection into mouse 
embryos. The EF1-CREODD mouse was crossed with a tdTomato-floxed GFP (mT/mG) 
reporter mouse that triggers a switch from TdTomato to GFP expression in the presence of Cre. 
Then, female double-transgenic mice were crossed with the FVB/N-Tg(MMTV-PyMT) male 
mice, which develops spontaneous breast cancer (Fig. 2a,b). The female triple-transgenic mice 
develop mammary tumors, in which cancer cells switch from TdTomato to permanent GFP 
expression upon exposure to hypoxia. To evaluate the best combination of allele number of the 
EF1-CREODD and TdTm transgenes in terms of sensitivity to hypoxia, we utilized an organoid 
model and performed studies in vitro. First, genotyping was performed to identify mice with 
either EF1-CREODD(+/+)TdTm(+/+), EF1-CREODD(+/-)TdTm(+/+), EF1-
CREODD(+/-)TdTm(+/-), or TdTm(+/+), (Fig. 2c,d). Then, organoids were generated from the 
mammary tumors that developed in triple transgenic mice (Fig. 2a). The organoids were cultured 
at various O2 concentrations depending upon the experiment. 
 
3.1.1 Determining the Role of TdTm Allele Number 
PyMT tumors from mice expressing either a single- or double-allele of TdTm transgenes were 
tested: EF1-CREODD(+/-)TdTm(+/+) and EF1-CREODD(+/-)TdTm(+/-). Organoids from each  
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Figure 3: Tumor organoids with single- and double-allele of the TdTm transgene a. Tumors from the hypoxia-
responsive triple-transgenic mice were used to generate organoids. The organoids were embedded into Matrigel. The 
organoids were cultured under hypoxic and normoxic conditions. b. Fluorescent images of frozen tissue sections of 
3T mouse tumor showing ductal carcinoma in situ (DCIS) and early carcinoma. c. Representative plots of flow 
cytometry data from organoids from EF1-CREODD(+/-)TdTm(+/+), EF1-CREODD(+/-)TdTm(+/-), and 
TdTm(+/+) mice embedded in Matrigel and cultured under 20% or 0.5% O2 for 20 days. d. Fluorescent images of 
tumor organoids embedded in Matrigel following 20 days of exposure to 20% and 5% O2. 
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mouse tumor were embedded in Matrigel and cultured at 20%, 5%, and 0.5% O2 for 20 days. 
Fluorescent microscopy and flow cytometry were used to assess the levels of TdTomato and 
GFP expression. Double transgenic mice, without the O2-responsive vector, were used as a 
control determine the background levels of GFP expression for both imaging and flow 
cytometry. EF1-CREODD(+/-)TdTm(+/+) organoids contained 2-fold more GFP+ cells than 
EF1-CREODD(+/-)TdTm(+/-) when exposed to 0.5% (Fig. 3c). For EF1-
CREODD(+/-)TdTm(+/+) and EF1-CREODD(+/-)TdTm(+/-), larger organoids cultured at 20% 
O2 showed GFP+ expression located within the center of the organoid (Fig 3d). The organoids 
cultured under 5% visually appeared more GFP+ than the 20% organoids. To summarize, 
organoids derived from mice with two alleles of the TdTm transgene contained more GFP+ cells 
under 0.5% O2 than the single allele TdTm organoids (Fig. 3 c,d). 
 
3.1.2 Determining the Role of EF1-CREODD Allele Number 
To determine if the copy number of the EF1-CREODD transgene affects sensitivity to hypoxia, 
organoids derived from EF1-CREODD(+/+)TdTm(+/+), EF1-CREODD(+/-)TdTm(+/+), and 
TdTm(+/+) mice were plated in Matrigel and exposed to 20% and 0.5% O2 for 20 days. On day 
20, organoids were analyzed for GFP and TdTom expression by flow cytometry (Fig. 4a). No 
significant difference in the number of GFP+ expressing cells was detected in the single- versus 
double-allele EF1-CREODD organoids (Fig. 4b,c). Organoids were also plated and exposed to 
20% and 5% O2 and no notable difference was detected between the EF1-
CREODD(+/+)TdTm(+/+) and EF1-CREODD(+/-)TdTm(+/+) (Fig. 4d). Under 5% O2 
conditions, GFP+ cells were localized in the center of the organoid similar to organoids cultured 
under 20% O2 conditions, but with visually brighter GFP cores. We expected a second allele of  
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Figure 4: Tumor organoids with single- and double-allele of the EF1-CREODD transgene a. Representative 
plots of flow cytometry data for organoids exposed to 20% and 0.5 % O2 for 20 days. b. Mean RFP intensity for 
flow cytometry of organoids exposed to 20% and 0.5% for 20 days (mean ± SEM, N = 1, n = 7000); ****P < 0.0001 
versus 20% TdTm(+/+) (one-way ANOVA); ####P<0.0001 (t-test). c. Mean GFP intensity for flow cytometry of 
organoids exposed to 20% and 0.5% for 20 days (mean ± SEM, N = 1, n = 6000); ****P < 0.0001 versus 20% 
TdTm(+/+) (one-way ANOVA); ####P<0.0001 (t-test). d. Fluorescent images of organoids from the triple-
transgenic mice following 20 days of exposure to 20% and 5% O2.  
EF1-CREODD to enhance sensitivity; however, taken together the results suggest that 
introducing a second allele of the EF1-CREODD transgene does not enhance sensitivity to 




Figure 5: EF1-CREODD(+/-)TdTm(+/+) tumor organoids at different O2 levels a. Representative plots of flow 
cytometry data for EF1-CREODD(+/-)TdTm(+/+) and TdTm(+/+) organoids exposed to 20%, 10%, 5%, and 0.5% 
O2  for 20 days. b. Fluorescent images of EF1-CREODD(+/-)TdTm(+/+) organoids exposed to 20% and 5% O2 for 
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20 days. c. Fluorescent images of EF1-CREODD(+/-)TdTm(+/+) organoids after 11 days. d. Mean RFP intensity for 
flow cytometry of organoids exposed to 20%, 10%, and 5% for 20 days (mean ± SEM, N = 1, n = 5000-8000); 
****P < 0.0001 versus 20% TdTm(+/+) (one-way ANOVA). e. Mean GFP intensity for flow cytometry of organoids 
exposed to 20%, 10%, and 5% for 20 days (mean ± SEM, N = 1, n = 5000-8000); ****P < 0.0001 versus 20% 
TdTm(+/+) (one-way ANOVA). f. Average organoid size using image analysis, corresponding to fluorescent images 
(b) (mean ± SEM, N = 1, n = 1000-2000); ****P < 0.0001 (t-test). 
 
3.2 Effect of Different O2 Levels in Hypoxia Fate-mapping Organoids 
Organoids were cultured under different O2 concentrations (20%, 10%, 5% and 0.5% O2) to 
determine the effect of O2 concentration on our hypoxia fate-mapping system. After 20 days of 
culture in Matrigel, the organoids derived from the mammary tumors of EF1-
CREODD(+/-)TdTm(+/+) were collected for flow cytometry analysis (Fig. 5a). Organoids 
cultured under 20% O2 showed a GFP+ core as described previously (Fig. 5b,c). Under 5% O2, 
most of the organoids appeared to have higher GFP expression in the cores and some of the 
organoids became completely GFP+ (Fig. 5b). The mean TdTom intensity decreased with lower 
O2 concentrations, whereas the mean GFP intensity increased as measured by flow cytometry 
analysis (Fig. 5d,e). Organoids exposed to 10%, 5%, and 0.5% O2 had 3.8X, 4.9X, and 6.9X 
higher levels of GFP expression, respectively, compared to those cultured under 20% O2. This 
indicated an inverse correlation between O2 level and GFP intensity. Interestingly, we observed 
that organoids showed slower growth under 5% when compared to 20% (Fig. 5f).  
 
3.3 Effect of Matrix Type in Hypoxia Fate-mapping Organoids 
Given that organoids cultured in Matrigel under 20% O2 conditions have GFP+ cores after long-
term culture, we sought to investigate this occurrence in collagen matrices. The collagen matrix 
promotes an invasive phenotype that has been previously described38, therefore, the organoids in 
collagen became less circular, more elongated, and invaded into the surrounding matrix (Fig.  
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Figure 6: EF1-CREODD(+/-)TdTm(+/+) tumor organoids embedded in Matrigel and collagen  
a. Fluorescent images of EF1-CREODD(+/-)TdTm(+/+) organoids cultured in Matrigel and collagen gels under 20% 
oxygen for 20 days. b. Circularity of organoids in 3D matrices for 20 days (mean ± SEM, N = 1, n = 1000-2000); 
****P<0.0001 (t-test). c. Image analysis of fluorescent images (a) was used to calculate average GFP intensity for 
organoids grown in 3D matrices for 20 days (mean ± SEM, N = 1, n = 1000-2000) ****P<0.0001 (t-test). d. Image 
analysis of fluorescent images (a) was used to calculate average RFP intensity for organoids grown in 3D matrices 
for 20 days (mean ± SEM, N = 1, n = 1000-2000) ****P<0.0001 (t-test).  
6a,b). While the GFP mean intensity increased in Matrigel, it was unchanged in a collagen 
matrix (Fig. 6c,d). 
 
3.4 Effect of Organoid Density on O2 Distributions in Matrices 
Given that the change in O2 levels over time could be a significant environmental cue that 
determines the fate of individual cells within organoids cultured in 3D matrices29, we wanted to 
characterize the O2 concentration in Matrigel and collagen matrices. Organoids were plated in 
both Matrigel and collagen and OXNANO nanoprobes were dispersed throughout the matrices. 
The nanoprobe signal was read through the bottom of the wells containing the organoid matrices  
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Figure 7: Tumor organoids embedded in Matrigel with OXNANO nanoprobes a. OXNANO nanoprobes were 
suspended in 3D matrices. b. Oxygen was measured for EF1-CREODD(+/-)TdTm(+/+) organoids cultured in 
Matrigel. Organoids were seeded at 2,000, 4,000, and 8,000 organoids per well (mean ± SEM, N = 1, n = 3). c. Time 
course fluorescent images of organoids in Matrigel. 
(Fig. 7a). Nanoprobes were also added to collagen and Matrigel matrices without organoids as a 
background control. The O2 concentration in the empty wells was approximately 15%. Over 10 
days in culture, the O2 levels in Matrigel decreased from 15% to under 6% in wells with an  
initial density of 8,000 organoids per well. A higher initial density of organoids caused greater 
decreases in O2 levels observed overtime (Fig. 7b,c). In summary, the initial number of  
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Figure 8: Tumor organoids embedded in collagen with OXNANO nanoprobes a. Oxygen was measured with 
OXNANO nanoprobes for EF1-CREODD(+/-)TdTm(+/+) organoids cultured in a collagen gel. Organoids were 
seeded at 2,000, 4,000, and 8,000 organoids per well (mean ± SEM, N = 1, n = 3). c. Time course fluorescent images 
of organoids in a collagen gel. 
organoids plated may cause a decrease in O2 over time and lead to hypoxic cores in Matrigel 
matrices. 
We performed a similar study in collagen matrices and detected no change in O2 levels 
over time (Fig. 8a). The organoids appear to invade into the surrounding collagen matrix over 
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time (Fig. 8b). Thus, the O2 content decreased in Matrigel with increasing density, but was 
unaffected for organoids embedded in collagen. 
 
3.5 Effect of MDA-MB-231 Spheroid Density on O2 Distribution in Matrigel  
The hypoxia fate-mapping system was first created using a cell line, as previously described. 
MDA-MD-231 cells were transfected with the two vectors to drive Cre expression under hypoxia 
and trigger a fluorescent switch from DsRed to GFP (Fig. 1). These cells were single cell cloned 
to ensure they were consistently responsive to 0.5% O2, but not to 3% O2 in terms of GFP 
activation. In order to further explore our results revealing a hypoxic GFP+ core in organoids 
cultured in Matrigel under 20% O2 conditions, we used the MDA-MB-231 hypoxia fate-mapping 
cell line to generate spheroids in the same conditions. Single cells were seed in Matrigel to create 
spheroids and OXNANO nanoprobes were dispersed throughout the matrix. Over time, the 
O2 levels decreased significantly in the wells with spheroids (Fig. 9a,b). Notably, higher cell 
seeding caused greater O2 decrease over time. At day 10, these hypoxia fate-mapping spheroids 
developed GFP+ cores indicating that the cores of these spheroids experience hypoxic conditions 
when cultured at 20% O2 for 10 days. However, the O2 level of the MDA-MB-231 spheroids is 
higher than the one registered for 3T tumor organoids at day 10. This could be due to the 
decreased oxygen consumption rate in the MDA-MB-231 system. It was reported that MDA-
MB-231 cells have an oxygen consumption rate of 16.8 amol s-1cell-1, while mouse carcinoma 
cells have a rate of 27 amol s-1cell-1, which could lead to less oxygen being consumed by the 
MDA-MB-231 spheroids43. These spheroids reached larger dimensions at day 10 than organoids 
so higher proliferation is likely related to a more drastic formation of a hypoxic core and 
activation of GFP expression.  
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Figure 9: MDA-MB-231 hypoxia fate-mapping cells embedded in Matrigel with OXNANO nanoprobes  
a. Oxygen was measured with OXNANO nanoprobes for MDA-MB-231 spheroids with the hypoxia fate-mapping 
system cultured in Matrigel. Cells were seeded at 40,000 and 80,000 cells per well (mean ± SEM, N = 1, n =2). b. 
Time course fluorescent images of organoids in Matrigel. 
 
3.6 Discussion 
 Recent developments in 3D culture systems facilitate better recapitulation of the tumor 
microenvironment and allow for long-term culture44–46. Besides capturing the 3D structure, there 
is still more to be uncovered about how organoids mimic the tumor microenvironment. For 
instance, current studies indicate  the behavior of cancer cells depends on the properties of the 
extracellular matrix and the diffusion of nutrients through it41,47,48. Oxygen distribution is a 
crucial factor in the tumor microenvironment and understanding how individual organoids 
experience this effect will determine how long-term culturing affects the characteristics of the 
organoids over time. Here, we utilized a hypoxia fate-mapping mouse model and OXNANO 
nanoprobes to investigate the overall O2 content of tumor organoids. First, we wanted to find the 
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most sensitive mouse model to conduct our future experiments. In our triple transgenic mouse 
model, the EF1-CREODD transgene expresses Cre, which activates the cleavage of TdTomato 
from the TdTm transgene, causing cells to permanently express GFP. We hypothesized that 
changing the copy number of our TdTm transgenes could affect the fluorescent signal under 
hypoxia. The double allele for the reporter transgene (TdTm) increased the sensitivity of the 
organoids when exposed to 0.5% O2 when compared to a single allele system (Fig. 3). 
Additionally, we expected that a double allele of the EF1-CREODD transgene would also affect 
the sensitivity due to increased Cre production. Markedly, no notable difference was detected 
between the double allele and the single allele of the EF1-CREODD transgene (Fig. 4). This is 
somewhat unexpected and we speculate that either more Cre is not being produced with a second 
allele or one allele creates enough Cre to saturate the system. Further studies would need to be 
conducted to determine which is the case. Taken together, the EF1-CREODD(+/-)TdTm(+/+) 
mouse was chosen to be used for future studies.  
 Next, we wanted to examine the effect of O2 concentration on our hypoxia fate-mapping 
organoids. They were embedded in Matrigel and cultured under different O2 concentrations 
(20%, 10%, 5% and 0.5% O2). As the oxygen decreased, the organoids became more GFP+, and, 
thus, more hypoxic. Interestingly, at 20% O2, the development of a hypoxic core was observed 
(Fig 5). Additionally, at 5% O2, some of the organoids become completely GFP+ possibly 
indicating that the gel containing the organoids could have a lower O2 content than 5%. Although 
it is known that organoids can develop hypoxic cores, very little is known about these cores and 
how they develop42,45,49. For an organoid cultured at 20% O2 for 20 days, GFP+ cells appear to 
be localized in the center with the TdTm+ cells lining the edge (Fig. 5). Previous studies found 
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that the cell proliferation depends on location and proliferation is higher for cells on the organoid 
rim30,45.  
Interestingly, we found that the average diameter of the organoids decreased from 20% to 
5% O2. In previous studies, it was found that hypoxia contributed to slower proliferation and 
growth5,50,51. We hypothesize that organoids under lower O2 are less proliferative and form 
smaller organoids. However, there is some evidence that shows low oxygen could enhance 
proliferation23,52. More studies investigating the difference between organoids at different 
oxygen levels would need to be conducted. 
 Next, since hypoxic cores formed in organoids embedded in Matrigel after long term 
culture, we explored the commonly used collagen I matrix to evaluate how hypoxic cores 
develop in this system. We found that organoids after 20 days in collagen had an invasive 
morphology and, therefore, did not form compact cores like observed in Matrigel (Fig. 6). Thus, 
while the GFP mean intensity increased in Matrigel, it did not change in a collagen matrix. In 
Matrigel, the organoids form large compact 3D structures, while in collagen the organoids spread 
out and elongate in several lengthy branches. The collagen matrix promotes an invasive 
phenotype that has been previously described38,38,53, We hypothesize that the failure of organoids 
to grow in 3D compact spheres results in them to not developing hypoxic GFP+ cores over this 
time period. Perhaps increasing the culturing time for organoids embedded in Matrigel could 
lead to more compact structures and GFP+ signal in our system. 
 There are several key determining factors for why these hypoxic cores could be forming: 
cell density, scaffold material, and cell activity. First, we wanted to see how initial organoid 
seeding density would affect the oxygen distribution in Matrigel, since cell density has been 
shown to affect the degree of oxygen depletion in previous studies52. First, we confirmed that the 
33 
organoids grew and proliferated throughout the experiment. Organoids plated in Matrigel 
showed that higher organoid initial seeding caused greater decreases in O2 levels observed 
overtime (Fig. 7). Additionally, the O2 levels decreased sharply initially and then seemed to 
begin to plateau over time. This could be due to the shift in metabolic activity of the organoids as 
the more hypoxic cores shift from aerobic to anaerobic metabolism. More studies would need to 
be done to confirm this hypothesis. Decreasing O2 levels resulted in hypoxic cores in compact 
spherical organoids in Matrigel. 
 Since hypoxic cores do not form in collagen over 20 days in culture, we hypothesized the 
oxygen distribution would not be affected in the more permeable collagen matrix52. We 
performed a similar study in collagen matrices by increasing organoid seeding density. We 
observed that although the organoids grow and proliferate throughout the experiment, initial 
number of organoids plated per well did not greatly affect O2 level. We hypothesize that these 
organoids do not develop a GFP+ core due to a more invasive phenotype in collagen that 
decreases the ability of cells to compact or the high permeability of collagen to O2. 
We also investigated the O2 depletion in hypoxia fate-mapping MDA-MB-231 derived 
spheroids in Matrigel. Higher cell seeding caused greater O2 decrease over time. Interestingly, 
although GFP+ cores were detected in this model, the O2 curves showed a less drastic depletion 
of O2. A previous study found that the MDA-MB-231 cells consumed oxygen at a rate of 16.8 
amol s-1 cell-1, while mouse carcinoma cells had a rate of is 27 amol s-1 cell-1.43 This could 
prevent the MDA-MB-231 spheroids from reaching as low O2 level as triple transgenic mouse 
tumor organoids. However, these spheroids reached larger dimensions at day 10 than organoids 
so higher proliferation is likely related to a more drastic formation of a hypoxic core and 
activation of GFP expression.  
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Our results can be utilized to design optimal conditions for 3D culture of breast cancer 
organoids. In conclusion, Matrigel is a better platform to study growth and spontaneous hypoxia, 
while collagen is a better matrix to investigate invasion. The 3D hypoxic environment allows for 
the study of hypoxic-nonhypoxic cell interactions. Therefore, developing consistent hypoxic 
cores could lead to a better understanding of tumor hypoxia, which could ultimately lead to drug 




Conclusion and Future Work 
4.1 Conclusion 
In this work, we investigated how O2 content affected a hypoxia fate-mapping organoid model. 
We found the most sensitive mouse model through organoid culture had a single allele of the 
oxygen sensing EF1-CREODD transgene and two alleles of the Cre-responsive TdTm transgene. 
Then, we exposed EF1-CREODD(+/-)TdTm(+/+) organoids to various oxygen levels to define 
the hypoxic sensing ability of the organoids. An inverse relationship between GFP+ cells and O2 
level was found. We, also discovered when culturing organoids at 20% O2, they develop GFP+ 
hypoxic cores after 20 days when embedded in Matrigel. However, when embedded in collagen, 
the organoids failed to generate hypoxic cores.  
 Furthermore, we monitored the O2 level in Matrigel and collagen over time using 
OXNANO nanoprobes. With increasing initial organoid seeding density, the O2 level decreased 
when embedded in Matrigel, but remained constant when embedded in collagen. This leads us to 
believe that the compact spherical structures formed in Matrigel allow for hypoxic core 
formation, while the invasive phenotype in collagen prevents it. Organoid culture in Matrigel 
may therefore be essential to recapitulate spontaneous hypoxic environments in vitro. 
Additionally, we used hypoxic fate-mapping MDA-MB-231 spheroids to monitor the oxygen 
distribution over time. We found similar results when embedded in Matrigel, which showed 
increasing initial cell seeding density leading to O2 depletion. This work warrants additional 
studies into the hypoxic core formation of organoids in Matrigel to develop an innovative 3D 
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tumor model that can better recreate the tumor niches under well-defined and reproducible 
conditions. 
 
4.2 Future Work 
Future research to further characterize the formation of the hypoxic cores in the organoid system 
is required. We could generate mixtures of Matrigel and collagen in attempts to produce an 
invasive model, which develops hypoxic cores to determine the role of hypoxic cells in invasion. 
It was found that a mixture of collagen and Matrigel represents more physiological ECM 
microenvironments for breast tissue38. Hence, this could lead to a better understanding of the 
mechanism of invasion. 
It would be interesting to utilize PrestoBlue and/or cell counting at each time point to 
determine the number of cells and their role in oxygen depletion. With the availability of 
nutrients becoming a concern in long-term 3D culture, we would like to model the oxygen 
transport in an organoid and spheroid using Michealis-Menten kinetics to further characterize the 
extent of the hypoxic cores. Additionally, we could develop cell lines from the hypoxia fate-
mapping mouse models to generate spheroids and determine whether the difference in oxygen 
consumption rate of human MDA-MB-231 cells and mouse carcinoma cells explains our 
observation. By using, flow cytometry to sort GFP+ and TdTom+ cells isolated from organoids, 
we could examine the differences between hypoxic/post hypoxic and oxygenated cells. For 
instance, we could characterize these differences both at the RNA and the phenotypic level.  
Additional studies about how hypoxic cores affect long term cultures are warranted since 
passaging of organoids can allow cultures to be maintained for months to years44–46. Given our 
observations, it is important to evaluate the possibility of spontaneous hypoxia in these systems 
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and determine whether hypoxic/post-hypoxic cells behave differently after several passages. Our 
fate mapping system could also provide insight into the origin of these cores. For instance, it 
could determine if the cores are a direct result of size or if they are influenced by other factors, 
such as matrix permeability, proximity to other organoids, or metabolic activity of specific cells. 
Lastly, we could use this high throughput organoid model with defined hypoxia for drug testing 
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